Semaglutide Improves eGFR Slope vs. Placebo Regardless of Baseline HbA1c and Blood Pressure in People With Type 2 Diabetes: A Post Hoc Analysis of SUSTAIN 6 and PIONEER 6

被引：0
|
作者：
Cherney, David [1 ]
Bosch-Traberg, Heidrun [2 ]
Hadjadj, Samy [3 ]
Kuhlman, Anja B. [2 ]
Rasmussen, Soren [2 ]
Tuttle, Katherine R. [5 ,6 ]
Heerspink, Hiddo J. L. [4 ]
机构：
[1] Univ Hlth Network, Toronto, ON, Canada
[2] Novo Nordisk, Soborg, Denmark
[3] Inst Thorax, Nantes, France
[4] Univ Med Ctr Groningen, Groningen, Netherlands
[5] Univ Washington, Spokane, WA USA
[6] Providence Washington, Spokane, WA USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2022年 / 33卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
SA-PO265
引用
收藏
页码：675 / 675
页数：1
相关论文
共 50 条
  • [1] Effect of semaglutide versus placebo on cardiovascular outcomes by baseline HbA1c: SUSTAIN 6 and PIONEER 6 post hoc analysis
    Mellbin, L. G.
    Bhatt, D. L.
    David, J. -P.
    Petrie, M. C.
    Rasmussen, S.
    Schytz, P. A.
    Vilsboll, T.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S304 - S305
  • [2] Semaglutide and cardiovascular outcomes by baseline HbA1c in diabetes: the SUSTAIN 6 and PIONEER 6 trials
    Mellbin, Linda G.
    Bhatt, Deepak L.
    David, Jens-Peter
    Ekstrom, Kathrine
    Petrie, Mark C.
    Rasmussen, Soren
    Vilsboll, Tina
    EUROPEAN HEART JOURNAL, 2024, 45 (15) : 1371 - 1374
  • [3] REDUCTION IN THE RATE OF EGFR DECLINE WITH SEMAGLUTIDE VS PLACEBO: A POST HOC POOLED ANALYSIS OF SUSTAIN 6 AND PIONEER 6
    Tuttle, Katherine
    Cherney, David
    Hadjadj, Samy
    Idorn, Thomas
    Mosenzon, Ofri
    Perkovic, Vlado
    Rasmussen, Soren
    Wolthers, Benjamin
    Bain, Stephen C.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 183 - 183
  • [4] Consistent Kidney Benefits With Semaglutide vs. Placebo Regardless of Baseline Urine Albumin Creatinine Ratio in Subjects With Type 2 Diabetes at High Cardiovascular Risk: A Post Hoc Analysis of SUSTAIN 6
    Heerspink, Hiddo J. L.
    Kuhlman, Anja B.
    Mann, Johannes F.
    Rasmussen, Soren
    Rossing, Peter
    Vrhnjak, Blaz
    Cherney, David
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 676 - 676
  • [5] Effect of semaglutide on kidney function across different levels of baseline HbA1c, blood pressure, body weight and albuminuria in SUSTAIN 6 and PIONEER 6
    Apperloo, Ellen M.
    Cherney, David Z., I
    Kuhlman, Anja Birk
    Mann, Johannes F. E.
    Rasmussen, Soren
    Rossing, Peter
    Tuttle, Katherine R.
    Vrhnjak, Blaz
    Heerspink, Hiddo J. L.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 40 (02) : 352 - 359
  • [6] Effects of Semaglutide on Stroke Subtypes in Type 2 Diabetes: Post Hoc Analysis of the Randomized SUSTAIN 6 and PIONEER 6
    Strain, W. David
    Frenkel, Ofir
    James, Martin A.
    Leiter, Lawrence A.
    Rasmussen, Soren
    Rothwell, Peter M.
    Ripa, Maria Sejersten
    Truelsen, Thomas C.
    Husain, Mansoor
    STROKE, 2022, 53 (09) : 2749 - 2757
  • [7] In type 2 diabetes, tirzepatide reduced HbA1c vs. semaglutide
    Gandhi, Gunjan Y.
    ANNALS OF INTERNAL MEDICINE, 2021, 174 (11) : JC127 - JC127
  • [8] Semaglutide Reduces Mace Consistently Across Baseline Triglyceride Levels in Patients With Type 2 Diabetes: A Post Hoc Analysis of the Sustain 6 and Pioneer 6 Trials
    Verma, Subodh
    Leiter, Lawrence A.
    Michelsen, Marie M.
    Orsted, David
    Rasmussen, Soren
    Bhatt, Deepak L.
    CIRCULATION, 2020, 142
  • [9] Effect of semaglutide on MACE by baseline kidney function in participants with type 2 diabetes and high risk of cardiovascular disease: SUSTAIN 6 and PIONEER 6 post hoc analysis
    Rossing, P.
    Bain, S.
    Bosch-Traberg, H.
    Frenkel, O.
    Heerspink, H. L.
    Rasmussen, S.
    Mellbin, L.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S24 - S25
  • [10] Effects of liraglutide and semaglutide on stroke subtypes in patients with type 2 diabetes: a post hoc analysis of the LEADER, SUSTAIN 6 and PIONEER 6 trials
    Strain, W. D.
    Holst, A. G.
    Rasmussen, S.
    Saevereid, H. A.
    James, M. A.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S130 - S131
12345